Business Wire

Karius Secures BARDA Contract to Expand Agnostic Detection of Pathogens

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc. today announced it has been awarded a contract from the Division of Research, Innovation, and Ventures (DRIVe), under the Biomedical Advanced ...
Nature

A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects

Mutation rates and biases in mutational sequence context can be influenced by endogenous cellular processes, environmental exposures, and genetic variation. All such mutagenic processes can leave ...
ascopubs.org

Predictive Effectiveness of Circulating Tumor DNA in Recurrent Early-Stage Non–Small Cell Lung Cancer: An Updated Meta-Analysis

We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...
ascopubs.org

Reflexed molecular testing to identify patients with biomarkers associated with tumor-agnostic FDA drug approvals.

Chemo-praidict eBC: A deep learning solution for predicting pathological complete response on biopsies of breast cancer patients treated with neoadjuvant chemotherapy. Big data analysis of outcomes in ...
KTLA

Adela to Present Data Highlighting Ability of its Tissue-Agnostic Test for MRD Detection and Response Monitoring to Predict Progression and Identify Non-Responders to ...

FOSTER CITY, Calif., May 30, 2025 /PRNewswire/ -- Adela, Inc., an innovator in blood testing for molecular residual disease (MRD) monitoring and early cancer detection through a proprietary ...
Business Wire

Fine Point Technologies Announces the Availability of Speed Master, a Vendor Agnostic Broadband Performance Testing Tool

HERNDON, Va.--(BUSINESS WIRE)--Fine Point Technologies today announced the release of Speed Master, a software module that enables highly efficient and scalable, vendor agnostic bulk speed testing.